Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine

BACKGROUND: Cytarabine (ara-C) is the major drug for the treatment of acute myeloid leukemia (AML), but cellular resistance to ara-C is a major obstacle to therapeutic success. The present study examined enhanced anti-apoptosis identified in 3 newly established nucleoside analogue-resistant leukemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishi, Rie, Shigemi, Hiroko, Negoro, Eiju, Okura, Miyuki, Hosono, Naoko, Yamauchi, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552348/
https://www.ncbi.nlm.nih.gov/pubmed/33046037
http://dx.doi.org/10.1186/s12885-020-07469-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552348/
https://www.ncbi.nlm.nih.gov/pubmed/33046037
http://dx.doi.org/10.1186/s12885-020-07469-x

Ejemplares similares